Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

An apolipoprotein A-I mimetic targets scavenger receptor A on tumor-associated macrophages: A prospective anticancer treatment?

Neyen C, Mukhopadhyay S, Gordon S, Hagemann T.

Oncoimmunology. 2013 Jun 1;2(6):e24461. Epub 2013 May 13.

2.

Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer.

Neyen C, Plüddemann A, Mukhopadhyay S, Maniati E, Bossard M, Gordon S, Hagemann T.

J Immunol. 2013 Apr 1;190(7):3798-805. doi: 10.4049/jimmunol.1203194. Epub 2013 Feb 27.

3.

Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F.

White CR, Smythies LE, Crossman DK, Palgunachari MN, Anantharamaiah GM, Datta G.

Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2631-9. doi: 10.1161/ATVBAHA.112.300167. Epub 2012 Sep 13.

4.
5.

An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI.

Song X, Fischer P, Chen X, Burton C, Wang J.

Int J Biol Sci. 2009 Oct 9;5(7):637-46.

6.

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.

Smythies LE, White CR, Maheshwari A, Palgunachari MN, Anantharamaiah GM, Chaddha M, Kurundkar AR, Datta G.

Am J Physiol Cell Physiol. 2010 Jun;298(6):C1538-48. doi: 10.1152/ajpcell.00467.2009. Epub 2010 Mar 10.

7.

Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A.

Rensen PC, Gras JC, Lindfors EK, van Dijk KW, Jukema JW, van Berkel TJ, Biessen EA.

Curr Drug Discov Technol. 2006 Jun;3(2):135-44.

PMID:
16925521
8.

miR-29a promotes scavenger receptor A expression by targeting QKI (quaking) during monocyte-macrophage differentiation.

Wang S, Zan J, Wu M, Zhao W, Li Z, Pan Y, Sun Z, Zhu J.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):1-6. doi: 10.1016/j.bbrc.2015.05.019. Epub 2015 Jun 6.

PMID:
26056009
9.

Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.

Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M.

Pathol Int. 2009 May;59(5):300-5. doi: 10.1111/j.1440-1827.2009.02369.x.

PMID:
19432671
10.

SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin.

Berwin B, Delneste Y, Lovingood RV, Post SR, Pizzo SV.

J Biol Chem. 2004 Dec 3;279(49):51250-7. Epub 2004 Sep 14.

11.

Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state.

Liu Q, Hamblin MR.

Int J Immunopathol Pharmacol. 2005 Jul-Sep;18(3):391-402.

13.

Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.

Kuchibhotla S, Vanegas D, Kennedy DJ, Guy E, Nimako G, Morton RE, Febbraio M.

Cardiovasc Res. 2008 Apr 1;78(1):185-96. Epub 2007 Dec 7.

14.

Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.

Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM.

Curr Opin Investig Drugs. 2003 Sep;4(9):1100-4. Review.

PMID:
14582455
15.

Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival.

Cieslewicz M, Tang J, Yu JL, Cao H, Zavaljevski M, Motoyama K, Lieber A, Raines EW, Pun SH.

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):15919-24. doi: 10.1073/pnas.1312197110. Epub 2013 Sep 17.

16.

Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.

Nayyar G, Garber DW, Palgunachari MN, Monroe CE, Keenum TD, Handattu SP, Mishra VK, Anantharamaiah GM.

Atherosclerosis. 2012 Oct;224(2):326-31. doi: 10.1016/j.atherosclerosis.2012.05.040. Epub 2012 Jun 23.

17.

Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36.

Crucet M, Wüst SJ, Spielmann P, Lüscher TF, Wenger RH, Matter CM.

Atherosclerosis. 2013 Jul;229(1):110-7. doi: 10.1016/j.atherosclerosis.2013.04.034. Epub 2013 May 9.

18.

Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.

Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM.

Circulation. 2002 Aug 27;106(9):1127-32.

19.

Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.

Handattu SP, Garber DW, Monroe CE, van Groen T, Kadish I, Nayyar G, Cao D, Palgunachari MN, Li L, Anantharamaiah GM.

Neurobiol Dis. 2009 Jun;34(3):525-34. doi: 10.1016/j.nbd.2009.03.007. Epub 2009 Apr 1.

PMID:
19344763
20.

Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice.

Takakura Y, Takagi T, Hashiguchi M, Nishikawa M, Yamashita F, Doi T, Imanishi T, Suzuki H, Kodama T, Hashida M.

Pharm Res. 1999 Apr;16(4):503-8.

PMID:
10227703

Supplemental Content

Support Center